REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,700 | -89.9% | 10,000 | -77.8% | 0.00% | -100.0% |
| Q2 2023 | $1,141,101 | -15.9% | 45,085 | +7.0% | 0.00% | 0.0% |
| Q1 2023 | $1,357,555 | -15.8% | 42,147 | -29.4% | 0.00% | +50.0% |
| Q3 2022 | $1,612,000 | +323.1% | 59,700 | +116.3% | 0.00% | – |
| Q2 2022 | $381,000 | +5.2% | 27,600 | +53.3% | 0.00% | – |
| Q4 2018 | $362,000 | -19.0% | 18,000 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $447,000 | -9.5% | 18,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $494,000 | +298.4% | 18,000 | +345.5% | 0.00% | – |
| Q1 2018 | $124,000 | -95.5% | 4,040 | -94.8% | 0.00% | -100.0% |
| Q4 2017 | $2,767,000 | – | 77,394 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |